The estimated Net Worth of Isaac Zacharias is at least $43 Million dollars as of 26 March 2024. Mr. Zacharias owns over 4,000 units of Shockwave Medical stock worth over $19,019,826 and over the last 6 years he sold SWAV stock worth over $23,354,394. In addition, he makes $658,551 as Chief commercial Officer at Shockwave Medical.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Zacharias SWAV stock SEC Form 4 insiders trading
Isaac has made over 60 trades of the Shockwave Medical stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 4,000 units of SWAV stock worth $1,150,680 on 26 March 2024.
The largest trade he's ever made was exercising 32,659 units of Shockwave Medical stock on 22 December 2021 worth over $131,616. On average, Isaac trades about 3,511 units every 19 days since 2019. As of 26 March 2024 he still owns at least 56,818 units of Shockwave Medical stock.
You can see the complete history of Mr. Zacharias stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Isaac Zacharias biography
Isaac Zacharias serves as Chief commercial Officer of the Company. Previously, Mr. Zacharias served as our General Manager of Structural Heart and Vice President of International Sales from March 2018 to November 2018. Prior to joining Shockwave Medical, Mr. Zacharias served as the Vice President, General Manager for the PCI Guidance business at Boston Scientific from July 2011 to March 2018. Prior to that, Mr. Zacharias also served as the Vice President, New Business Development for Boston Scientific where he negotiated investments and acquisitions for the Cardiology, Rhythm Management and Vascular business units. Mr. Zacharias began his career as an R&D engineer and has held a variety of clinical and marketing roles.
What is the salary of Isaac Zacharias?
As the Chief commercial Officer of Shockwave Medical, the total compensation of Isaac Zacharias at Shockwave Medical is $658,551. There are 3 executives at Shockwave Medical getting paid more, with Douglas Godshall having the highest compensation of $2,208,320.
How old is Isaac Zacharias?
Isaac Zacharias is 45, he's been the Chief commercial Officer of Shockwave Medical since 2018. There are 13 older and 2 younger executives at Shockwave Medical. The oldest executive at Shockwave Medical Inc. is John M. Adams, 74, who is the Co-Founder and Technical Advisor.
What's Isaac Zacharias's mailing address?
Isaac's mailing address filed with the SEC is C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA, CA, 95054.
Insiders trading at Shockwave Medical
Over the last 6 years, insiders at Shockwave Medical have traded over $488,603,927 worth of Shockwave Medical stock and bought 30,000 units worth $510,000 . The most active insiders traders include James E Deerfield Mgmt L.P...., Antoine Papiernik, and Capital Vii Fcpr Sofinnova. On average, Shockwave Medical executives and independent directors trade stock every 8 days with the average trade being worth of $10,693,924. The most recent stock trade was executed by Trinh Phung on 17 May 2024, trading 19,763 units of SWAV stock currently worth $121,740.
What does Shockwave Medical do?
shockwave medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. inspired by 30-years of safety and efficacy in kidney stone treatment, our lithoplasty® family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. lithoplasty devices use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. an integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. in peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, lithoplasty technology demonstrated safety and consistent procedure success with low procedural complications. the technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatmen
What does Shockwave Medical's logo look like?
Complete history of Mr. Zacharias stock trades at Shockwave Medical
Shockwave Medical executives and stock owners
Shockwave Medical executives and other stock owners filed with the SEC include:
-
Douglas Godshall,
President, Chief Executive Officer, Director -
Daniel Puckett,
Chief Financial Officer -
Douglas E. Godshall,
Pres, CEO & Director -
Isaac Zacharias,
Chief commercial Officer -
Isaac Zacharias,
Chief Commercial Officer -
Daniel Puckett MBA,
CFO, Principal Financial Officer & Sec. -
Colin Cahill,
Independent Director -
F. Thomas Watkins,
Independent Director -
Antoine Papiernik,
Independent Director -
Frederic Moll,
Independent Director -
C. Raymond Larkin,
Independent Chairman of the board -
Laura Francis,
Independent Director -
Maria Sainz,
Director -
Trinh Phung,
Chief Accounting Officer, Principal Accounting Officer & VP of Fin. -
Robert Fletcher,
VP of Marketing -
Rob Williamson Jr.,
VP of Sales -
Hajime Tada J.D.,
Gen. Counsel & Sec. -
Debbie Kaster,
Head of Investor Relations -
Mike Maszy,
VP of Operations -
John M. Adams,
Co-Founder and Technical Advisor -
Daniel Hawkins,
Founder and Sr. Advisor -
Sara Toyloy,
Director -
Capital Vii Fcpr Sofinnova,
10% owner -
James E Deerfield Mgmt L.P....,
-
Dan Puckett,
Chief Financial Officer -
Associates Vii, L.P.Venrock...,
-
Trinh Phung,
SVP, Finance -
Kevin J. Ballinger,
Director -
Renee Gaeta,
Chief Financial Officer